靜脈注射用溶液的美國市場:各溶液類型，各包裝型態(安瓿，管瓶，濾芯，瓶，袋子)，各適應症，各終端用戶 - 規模，佔有率，預測，機會分析(2022年～2028年)

U.S Intravenous Solution Market, by Solution Type, By Packaging (Ampules, Vials, Cartridges, Bottles, Bags, By Indication, and By End User - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日期: 2022年05月02日 | 出版商:

Coherent Market Insights | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

燒燙傷治療管理所使用的靜脈注射用溶液，有蛋白質為基礎的膠體，高滲液，等滲壓晶質液等。因為美國燒燙傷的發生數量增加，預計該市場在預測期間內擴大。

本報告提供美國的靜脈注射用溶液市場相關調查分析，市場動態，各市場區隔的市場分析，各地區的市場分析，競爭情形等相關的系統性資訊。

簡介
- 市場佔有率分析:2022年、2028年(%)
- 與前一年同期比較成長分析:2017年～2028年
- 市場區隔趨勢
生理食鹽水
- 簡介
- 市場規模、預測，與前一年同期比較成長率(2017年～2028年)
- 通常生理食鹽水(0.9% NaCl)
- 高滲食鹽水
聚葡萄糖
乳酸林格氏液
氨基酸
維生素和礦物質
肝素、微量礦物質
混合溶液

第5章美國的靜脈注射用溶液市場:各袋子類型(2017年～2028年)

簡介
- 市場佔有率分析:2022年、2028年(%)
- 與前一年同期比較成長分析:2017年～2028年
- 市場區隔趨勢
高容量袋子(250ml以上)
- 簡介
- 市場規模、預測，與前一年同期比較成長率(2017年～2028年)
少容量袋子(不滿250ml)

第6章美國的靜脈注射用溶液市場:各用途(2017年～2028年)

簡介
- 市場佔有率分析:2022年、2028年(%)
- 與前一年同期比較成長分析:2017年～2028年
- 市場區隔趨勢
基本IV溶液
- 簡介
- 市場規模、預測，與前一年同期比較成長率(2017年～2028年)
營養IV溶液
血液IV溶液
藥物IV溶液
清洗IV溶液

第7章美國的靜脈注射用溶液市場:各終端用戶(2017年～2028年)

簡介
- 市場佔有率分析:2022年、2028年(%)
- 與前一年同期比較成長分析:2017年～2028年
- 市場區隔趨勢
醫院
- 簡介
- 市場規模、預測，與前一年同期比較成長率(2017年～2028年)
診所
門診病人手術中心

第8章競爭情形

企業簡介
- Baxter International Inc.
- ICU Medical, Inc.
- B. Braun Melsungen Ag
- Grifols, S.A.
分析師的見解

第9章 Section

簡介目錄

Product Code: CMI3400

Intravenous solutions are supplemental fluids used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route of administration is not possible in an individual. Intravenous therapy is a medical technique that delivers fluids, medications and nutrition directly into a person's vein. Intravenous solution therapy is an efficient and effective way of supplying fluids directly into the intravascular fluid compartment of the body. Intravascular fluids are used to replace electrolyte losses, and also for administering medications and blood products. Intravenous solutions are also known as Intravenous fluids. Some of the major reasons when patient needs to take fluids intravenously, rehydration after becoming dehydrated from illness, treatment of an infection using antibiotics, cancer treatment through chemotherapy drugs, management of pain using certain medication. Fluids for such treatments consists of water with electrolytes, sugar, or medications. The amount of intravenous solution can be regulate in the body by two ways, manually or by using electric pump, which uses a pump to regulate intravenous fluid. Types of intravenous solutions are saline, dextran, lactated Ringer's, amino acid, vitamins & minerals, heparin and trace elements and mixed solutions.

Market Dynamics

The intravenous solutions used during burn care management are protein-based colloids, hypertonic solutions, isotonic crystalloids, and others. The increasing number of burn incidences in the U.S. is expected to boost the U.S. intravenous solutions market over the forecast period. For instance, according to the Burn Association of America, approximately 486,000 fire or burn injuries were reported at emergency departments in 2016 in the U.S.

However, growth of the U.S. intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in August 2015, Covidien LLC, recalled their product Monoject 0.9% Saline Flush Prefill Double Pouch over the packaging process control reason. As there was defect in packaging of monoject 0.9% saline flush pouch.

Key features of the study:

This report provides an in-depth analysis of global U.S intravenous solution market, provides market size (US$ Million), and compound annual growth rate (CAGR %), for the forecast period (2022 - 2028), considering 2021 as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
It profiles key players in the U.S intravenous solution market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study are B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA, LLC, Grifols, S.A., JW Life Science, Amanta Healthcare, Salius Pharma Private Limited, Axa Parenterals Ltd., Vifor Pharma Management Ltd., Icu Medical, Inc., and Pfizer Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The U.S intravenous solution market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for dialysis market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

U.S Intravenous Solution Market, By Solution Type:
- Saline
  - Normal Saline (0.9% NaCl)
  - Hypertonic saline
- Dextran
  - D5W (5% dextrose in water)
  - Analog Hypertonic Saline
- Lactated Ringer's
- Amino Acid
- Vitamins & Minerals
- Heparin and trace elements
- Mixed Solutions
U.S Intravenous Solution Market, By Packaging Type:
- Ampules
- Vials
- Cartridges
- Bottles
- Bags
  - Large Volume Bags (greater than 250ml)
  - Small Volume Bags (less than 250ml)
U.S Intravenous Solution Market, By Indication:
- Oncology
- Post-Operative Care
- General Medicine
- Burn Management
- Pulmonary Disorders
- Cardiovascular Diseases
- Others
U.S Intravenous Solution Market, By End User:
- Hospitals
  - Clinics
  - Ambulatory Surgery Centres
  - Home care Settings
  - Others
Company Profiles
- B. Braun Melsungen AG
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Baxter International Inc.
- Fresenius Kabi USA, LLC
- Grifols, S.A.
- Jw Life Science
- Amanta Healthcare
- Salius Pharma Private Limited
- Axa Parenterals Ltd.
- Vifor Pharma Management Ltd.
- Icu Medical, Inc.
- Pfizer Inc.

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Solution Type
- Market Snippet, By Bag Type
- Market Snippet, By Application
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Epidemiology Analysis
Porter's Five Forces model

4. U.S. Intravenous Solutions Market, By Solution Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Saline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Normal Saline (0.9% NaCl)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Hypertonic Saline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Dextran
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Lactated Ringer's
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Amino Acid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Vitamins & Minerals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Heparin and trace elements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Mixed Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. U.S. Intravenous Solutions Market, By Bag Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Large Volume Bags (greater than 250ml)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Small Volume Bags (less than 250ml)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. U.S. Intravenous Solutions Market, By Application, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Basic IV Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Nutritional IV Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Blood IV Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Drug IV Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Irrigation IV Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. U.S. Intravenous Solutions Market, By End User , 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Home care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Competitive Landscape

Company Profiles
- Baxter International Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- ICU Medical, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- B. Braun Melsungen Ag
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Grifols, S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views